跳至主要内容
临床试验/JPRN-UMIN000053439
JPRN-UMIN000053439已完成Unknown

Effect of noodles containing calcium alginate on postprandial blood sugar levels -Placebo-controlled, randomized, double-blind, crossover study- - Effect of noodles containing calcium alginate on postprandial blood sugar levels

Takasaki University of Health and Welfare0 个研究点目标入组 9 人开始时间: 2024年1月30日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
入组人数
9

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Persons who are taking medicines or supplements that may affect sugar metabolism. Currently undergoing treatment for diabetes or who is judged to need treatment. Persons with serious diseases such as diabetes, liver disease, kidney disease, hypertension, ischemic heart disease, digestive system disease, etc., or those with a history of such diseases. Persons who have some kind of disease and are receiving medication and are deemed unsuitable as subjects by the research doctor. person. Persons who regularly use medicines, health foods, or supplements that affect blood lipids. Persons who are at risk of developing allergic symptoms regarding the test noodles (flour, etc.). Persons whose BMI value obtained from the temporary registration questionnaire falls outside the 95% confidence interval from the average BMI value of all applicants. Persons whose fasting blood sugar level is higher than 125 mg/dL or lower than 60 mg/dL as a result of the screening test. Persons whose HbA1c (NGSP) value is 6.5% or higher as a result of the screening test. If any of the screening test results are positive for HIV antigen/antibody, HBV, HCV, or syphilis. Persons with obvious abnormalities found in hematological or biochemical tests.

研究者

相似试验